Cargando…

Induction of Tumor Necrosis Factor in Mice by Recombinant Human Macrophage Colony‐stimulating Factor

The effect of recombinant human macrophage colony‐stimulating factor (rhM‐CSF) on endogenous production of tumor necrosis factor (TNF) was investigated in mice. The intravenous injection of lipopolysaccharide (LPS) after the administration of rhM‐CSF via the same route induced the production of endo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakurai, Takuma, Suzu, Shinya, Yamada, Muneo, Yanai, Nobuya, Kawashima, Takuji, Hatake, Kiyohiko, Takaku, Fumimaro, Motoyoshi, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1994
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919345/ https://www.ncbi.nlm.nih.gov/pubmed/8106292 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02889.x

Ejemplares similares

Augmentation of Cancer Chemotherapy by Preinjection of Human Macrophage Colony‐stimulating Factor in L1210 Leukemic Cell‐inoculated Mice
por: Douzono, Miyuki, et al.
Publicado: (1995)

Enhancement of the Antibody‐dependent Tumoricidal Activity of Human Monocytes by Human Monocytic Colony‐stimulating Factor
por: Suzu, Shinya, et al.
Publicado: (1990)

Effect of Human Macrophage Colony‐stimulating Factor on Granulopoiesis and Survival in Bone‐marrow‐transplanted Mice
por: Yanai, Nobuya, et al.
Publicado: (1990)

MORPHOLOGIC CHANGES OF NEUTROPHILS IN MYELODYSPLASTIC SYNDROME TREATED WITH RECOMBINANT HUMAN GRANULOCYTE COLONY‐STIMULATING FACTOR
por: Toyama, Keisuke, et al.
Publicado: (1988)

Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor
por: Ohyashiki, Kazuma, et al.
Publicado: (1989)

Effects of the in vivo Administration of Recombinant Human Granulocyte Colony‐stimulating Factor Following Cytotoxic Chemotherapy on Granulocytic Precursors in Patients with Malignant Lymphoma
por: Ema, Hideo, et al.
Publicado: (1989)

Binding Properties and Proliferative Effects of Human Recombinant Granulocyte‐Macrophage Colony‐stimulating Factor in Primary Leukemia and Lymphoma
por: Piao, Yun‐Feng, et al.
Publicado: (1989)

Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis
por: Takasugi, Koji, et al.
Publicado: (2006)

Characteristics of Granulocyte‐Macrophage Colony Formation in Chronic Myelomonocytic Leukemia: A Comparative Study with Other Myelodysplastic and Myeloproliferative Disorders
por: Yuo, Akira, et al.
Publicado: (1990)

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
por: Yokoyama, Masahiro, et al.
Publicado: (2021)

Combined Effects of Differentiation‐inducing Factor and Other Cytokines on Induction of Differentiation of Mouse Myeloid Leukemic Cells
por: Yamamoto‐Yamaguchi, Yuri, et al.
Publicado: (1989)

Enhanced Antitumor Effect of Recombinant Human Tumor Necrosis Factor in Combination with Recombinant Human Granulocyte Colony‐stimulating Factor in BALB/c Mice
por: Maeda, Masahiro, et al.
Publicado: (1993)

Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor.
por: Mahony, S. M., et al.
Publicado: (1988)

Macrophage Colony‐stimulating Factor Induces the Growth and Differentiation of Normal Pregnancy Human Cytotrophoblast Cells and Hydatidiform Moles but Does Not Induce the Growth and Differentiation of Choriocarcinoma Cells
por: Saito, Shigeru, et al.
Publicado: (1994)

Induction of T-cell mitogenic unresponsiveness by recombinant human granulocyte colony-stimulating factor – a reply
por: Reyes, E, et al.
Publicado: (2000)

Mutations of N‐ras Oncogene in Myelodysplastic Syndromes and Lcukemias Detected by Polymerase Chain Reaction
por: Mano, Hiroyuki, et al.
Publicado: (1989)

Induction of circulating phospholipase A(2) by intravenous administration of recombinant human tumour necrosis factor
por: Pruzanski, Waldemar, et al.
Publicado: (1992)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

Induction of T-cell mitogenic unresponsiveness by recombinant human granulocyte colony-stimulating factor (rHuG-CSF)
por: Rutella, S, et al.
Publicado: (2000)

Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.
por: MÃ¤nnel, D. N., et al.
Publicado: (1989)

Role of Bone Marrow-Derived Monocytes/Macrophages in the Repair of Mucosal Damage Caused by Irradiation and/or Anticancer Drugs in Colitis Model
por: Takaba, Junji, et al.
Publicado: (2010)

Epstein-Barr virus gastric ulcer associated with ruxolitinib
por: Kusano, Yoshiharu, et al.
Publicado: (2016)

Klebsiella pneumoniae primary liver abscess associated with ruxolitinib
por: Kusano, Yoshiharu, et al.
Publicado: (2016)

Clinical Application of Phorbol Diester‐induced Leukemic Cell Differentiation for the Definite Diagnosis of Acute Leukemias
por: Ohta, Masatsugu, et al.
Publicado: (1988)

Anti‐tumor Effects of Interleukin‐4 and Interleukin‐5 against Mouse B Cell Lymphoma and Possible Mechanisms of Their Action
por: Wu, Hua‐Lang, et al.
Publicado: (1992)

Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo
Publicado: (1989)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors
por: Sugihara, Tsutomu, et al.
Publicado: (2017)

Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.
por: Veldhuis, G. J., et al.
Publicado: (1997)

Tumor Necrosis Factor‐a Stimulates Colony Formation by a Megakaryoblastic Leukemia Cell Line, CMK
por: Akiyama, Yasuto, et al.
Publicado: (1992)

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients.
por: Bronchud, M. H., et al.
Publicado: (1988)

Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor
Publicado: (1990)

Development of Wolffia arrhiza as a Producer for Recombinant Human Granulocyte Colony-Stimulating Factor
por: Khvatkov, Pavel, et al.
Publicado: (2018)

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia
por: Kemp, Kevin C., et al.
Publicado: (2022)

The response of human myeloid leukaemia xenografts to human recombinant tumour necrosis factor.
por: Clutterbuck, R. D., et al.
Publicado: (1989)

Molecular and Biochemical Characterization of Recombinant Guinea Pig Tumor Necrosis Factor-Alpha
por: Dirisala, Vijaya R., et al.
Publicado: (2015)

Differences in tumour necrosis factor productive ability among rodents.
por: Haranaka, K., et al.
Publicado: (1984)

Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats
por: Papalois, Apostolos E., et al.
Publicado: (2019)

Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation
Publicado: (1992)

Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_9fsa4sjvdoaco8vkscdp3rrhbd